20. DIFFERENTIATED THYROID CANCER ASSOCIATED WITH HASHIMOTO'S THYROIDITIS: CHALLENGES IN THYROID-CONSERVING SURGERY

Nguyen Giang Son1, Tran Ngoc Luong1, Nguyen Van Loc1
1 National Hospital of Endocrinology

Main Article Content

Abstract

Summary:
Differentiated thyroid carcinoma in the setting of Hashimoto's thyroiditis generates a variety of morphological, histological, and functional alterations in the thyroid gland, presenting major challenges to thyroid-conserving surgery. Evaluate the pathological characteristics that influence the decision to thyroid conserving surgery.


Objective: 39 patients with thyroid cancer tumors <2 cm on a background of Hashimoto's thyroiditis underwent lobectomy ± central lymph node dissection from May, 2023 to May 2024, in National Hospital of Endocrinology


Material and methods: Retrospective descriptive study.


Results: The majority of patients were middle-aged females (38.2 ± 8.9 years) with a history of chronic thyroiditis for more than three years. Anti-TPO antibodies were detected in 97.4% of the patients. Tumors greater than 1 cm were detected in 87.2% of cases, while ultrasonography revealed questionable lymph nodes in 89.7%. Only 2.6% obtained positive FNA results for metastatic lymph nodes. Lobectomy with central lymph node dissection was the main treatment approach, with 100% of cases being papillary thyroid carcinoma. Lymph node metastasis occurred in 23.5% of patients. The only postoperative complication was hoarseness, affecting 10% of patients. After 3 months, no recurrence or metastasis was detected, but only 64.1% reached the treatment goal in euthyroid status.


Conclusion: Thyroid-conserving surgery for differentiated thyroid cancer on the background of Hashimoto's thyroiditis presents several challenges but is a safe and effective treatment option in the early stages of the disease.

Article Details

References

[1] Lee, Ju-Han, et al., The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. European journal of endocrinology, 2013; 168(3), pp. 343-349.
[2] Durfee, S. M., et al., Sonographic appearance of thyroid cancer in patients with Hashimoto thyroiditis. J Ultrasound Med, 2015; 34(4), pp. 697-704.
[3] Min, Y., et al., Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis. Front Endocrinol (Lausanne), 2021; 12, p. 713475.
[4] Nguyễn Trung Dũng (2022), Chỉ định và kết quả sớm phẫu thuật mổ mở cắt một thùy tuyến giáp điều trị UTTG thể biệt hóa tại Bệnh viện Nội tiết Trung ương. Luận văn Thạc sỹ y học. Trường Đại học Y Hà Nội, 2022.
[5] Đinh Ngọc Triều, Kết quả phẫu thuật nội soi cắt một thùy tuyến giáp trong điều trị ung thư tuyến giáp thể biệt hóa nguy cơ thấp tại bệnh viện Nội tiết Trung ương. Luận văn Thạc sỹ y học. Trường Đại học Y Hà Nội, 2020.
[6] Haugen, B. R., et al., 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016; 26(1), pp. 1-133.